dasatrue

Introduction to dasatrue

Dasatrue is a medication available in tablet form, primarily used to treat certain types of cancer. Dasatrue is specifically indicated for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), which are cancers affecting the blood and bone marrow.

Composition of dasatrue

Dasatrue contains the active ingredient dasatinib, which is a tyrosine kinase inhibitor. This compound works by blocking specific proteins that promote the growth of cancer cells, thereby slowing or stopping their proliferation.

Uses of dasatrue

• Treatment of chronic myeloid leukemia (CML)
• Treatment of acute lymphoblastic leukemia (ALL)

Side effects of dasatrue

• Common side effects: Low blood cell counts, increased risk of infection, fluid retention, and swelling.
• Serious side effects: Severe liver problems, heart issues, and significant fluid retention.

Precautions of dasatrue

Dasatrue should not be used by individuals allergic to dasatinib or those with severe liver problems. Regular monitoring is essential due to potential fluid retention and heart-related issues. It is important to follow your healthcare provider's advice and report any unusual symptoms immediately.

How to Take dasatrue

Dasatrue is typically taken as a tablet, with an initial adult dose of 100 mg once daily. It can be taken with or without food, but should not be consumed with grapefruit. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of dasatrue

Dasatrue, containing the active ingredient dasatinib, belongs to the therapeutic class of tyrosine kinase inhibitors. It is primarily used for treating chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Manufactured for effective cancer treatment, dasatrue is a key medication in managing these conditions. Always consult your healthcare provider for personalized advice and regular monitoring while on dasatrue.